首页> 美国政府科技报告 >Pretreatment with Recombinant Murine Tumor Necrosis Factor Alpha/Cachectin and Murine Interleukin 1 Alpha Protects Mice from Lethal Bacterial Infection.
【24h】

Pretreatment with Recombinant Murine Tumor Necrosis Factor Alpha/Cachectin and Murine Interleukin 1 Alpha Protects Mice from Lethal Bacterial Infection.

机译:用重组小鼠肿瘤坏死因子α/ Cachectin和小鼠白细胞介素1α预处理使小鼠免于致死性细菌感染。

获取原文

摘要

Tumor necrosis factor alpha/cachectin (TNF/C) is a well -characterized peptide that may, through its diverse effects on cells, mediate many normal host functions, including tissue remodeling and the mobilization of energy reserves required by the infected host. Tumor necrosis factor/cachectin (TNF/C) is the principal mediator of bacterial endotoxin-induced shock and death. We found that the C3H/HeJ mouse, which is less able able to produce TNF/C in response to endotoxin, has a thousand-fold greater susceptibility to lethal infection with E. coli than the TNF-responsive congenic mouse, CeH/HeN. This surprising finding suggested that this lethal peptide may also be involved in host protection. To test this hypothesis we pre-treated the C3H/HeJ mouse with a combination of recombinant murine TNF/C alpha and interleukin-1 alpha. This combination protected these mice against an intraperitoneal bacterial challenge of more than 20 LD 50s (nearly 200 CFU) and which grew to a level of >107 CFU/ml of blood and per gram liver in untreated mice. This suggests a significant role for these cytokines in host defenses against invasive infections that require bacterial replication within the host. These protective mechanisms may not be important for less virulent organisms. These findings may have important implications for the proposed use of anti-TNF/C agents in the treatment of septic shock. Reprints. (aw)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号